Chapter 10 Hetero-Oligomerization of Chemokine Receptors

Methods in Enzymology

Volumn 461, Issue B, 2009, Pages 207-225

  Appelbe, Shirley ^a   Milligan, Graeme ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; EPITOPE;

BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; DATA ANALYSIS; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; IMMUNOPRECIPITATION; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW;

CELL LINE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; IMMUNOPRECIPITATION; LUMINESCENT MEASUREMENTS; PROTEIN MULTIMERIZATION; RECEPTORS, CHEMOKINE;

EID: 65749105427     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(09)05410-X     Document Type: Review

References (53)

1. Ayoub M.A., Couturier C., Lucas-Meunier E., Angers S., Fossier P., Bouvier M., and Jockers R. Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer. J. Biol. Chem. 277 (2002) 21522-21528
2. Ayoub M.A., Levoye A., Delagrange P., and Jockers R. Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers. Mol. Pharmacol. 66 (2004) 312-321
3. Babcock G.J., Farzan M., and Sodroski J. Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor. J. Biol. Chem. 278 (2003) 3378-3385
4. Bazin H., Trinquet E., and Mathis G. Time resolved amplification of cryptate emission: A versatile technology to trace biomolecular interactions. J. Biotechnol. 82 (2002) 233-250
5. Benkirane M., Jin D.Y., Chun R.F., Koup R.A., and Jeang K.T. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32. J. Biol. Chem. 272 (1997) 30603-30606
6. Chen C., Li J., Bot G., Szabo I., Rogers T.J., and Liu-Chen L.Y. Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor. Eur. J. Pharmacol. 483 (2004) 175-186
7. Dean M., Carrington M., Winkler C., Huttley G.A., Smith M.W., Allikmets R., Goedert J.J., Buchbinder S.P., Vittinghoff E., Gomperts E., Donfield S., Vlahov D., et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273 (1996) 1856-1862
8. El Asmar L., Springael J.Y., Ballet S., Andrieu E.U., Vassart G., and Parmentier M. Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers. Mol. Pharmacol. 67 (2005) 460-469
9. Fotiadis D., Liang Y., Filipek S., Saperstein D.A., Engel A., and Palczewski K. Atomic-force microscopy: Rhodopsin dimers in native disc membranes. Nature 421 (2003) 127-128
10. Forster T. Zwischenmoleckulare Energiewanderung und fluoreszenz. Ann. Phys. 2 (1948) 54-75
11. Gandia J., Galino J., Amaral O.B., Soriano A., Lluis C., Franco R., and Ciruela F. Detection of higher-order G protein-coupled receptor oligomers by a combined BRET-BiFC technique. FEBS Lett. 582 (2008) 2979-2984
12. Heim R., Prasher D.C., and Tsien R.Y. Wavelength mutations and posttranslational autoxidation of green fluorescent protein. Proc. Natl. Acad. Sci. USA 91 (1994) 12501-12504
13. Hu C.D., Chinenov Y., and Kerppola T.K. Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol. Cell 9 (2002) 789-798
14. Hu C.D., and Kerppola T.K. Simultaneous visualization of multiple protein interactions in living cells using multicolor fluorescence complementation analysis. Nat. Biotechnol. 21 (2003) 539-545
15. Huang Y., Paxton W.A., Wolinsky S.M., Neumann A.U., Zhang L., He T., Kang S., Ceradini D., Jin Z., Yazdanbakhsh K., Kunstman K., Erickson D., et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2 (1996) 1240-1243
16. Issafras H., Angers S., Bulenger S., Blanpain C., Parmentier M., Labbe-Jullie C., Bouvier M., and Marullo S. Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors. J. Biol. Chem. 277 (2002) 34666-34673
17. Kroeger K.M., and Eidne K.A. Study of G-protein-coupled receptor-protein interactions by bioluminescence resonance energy transfer. Methods Mol. Biol. 259 (2004) 323-333
18. Liang Y., Fotiadis D., Filipek S., Saperstein D.A., Palczewski K., and Engel A. Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J. Biol. Chem. 278 (2003) 21655-21662
19. Liu R., Paxton W.A., Choe S., Ceradini D., Martin S.R., Horuk R., MacDonald M.E., Stuhlmann H., Koup R.A., and Landau N.R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiplyexposed individuals to HIV-1 infection. Cell 86 (1996) 367-377
20. Lopez-Gimenez J.F., Canals M., Pediani J.D., and Milligan G. The alpha 1b-adrenoceptor exists as a higher-order oligomer: Effective oligomerization is required for receptor maturation, surface delivery, and function. Mol. Pharmacol. 71 (2007) 1015-1029
21. Matz M.V., Fradkov A.F., Labas Y.A., Savitsky A.P., Zaraisky A.G., Markelov M.L., and Lukyanov S.A. Fluorescent proteins from nonbioluminescent Anthozoa species. Nat. Biotechnol. 17 (1999) 969-973
22. Maurel D., Comps-Agrar L., Brock C., Rives M.L., Bourrier E., Ayoub M.A., Bazin H., Tinel N., Durroux T., Prezeau L., Trinquet E., and Pin J.P. Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: Application to GPCR oligomerization. Nat. Methods 5 (2008) 561-567
23. Mellado M., Rodriguez-Frade J.M., Vila-Coro A.J., de Ana A.M., and Martinez A. Chemokine control of HIV-1 infection. Nature 400 (1999) 723-724
24. Mellado M., Rodriguez-Frade J.M., Vila-Coro A.J., Fernandez S., Martin D.A., Jones D.R., Toran J.L., and Martinez A. Chemokine receptor homo- or heterodimerization activates distinct signaling pathways. EMBO J. 20 (2001) 2497-2507
25. Mercier J.F., Salahpour A., Angers S., Breit A., and Bouvier M. Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J. Biol. Chem. 277 (2002) 44925-44931
26. Michael N.L., Louie L.G., and Sheppard H.W. CCR5-delta 32 gene deletion in HIV-1 infected patients. Lancet 350 (1997) 741-742
27. Milligan G., and Bouvier M. Methods to monitor the quaternary structure of G protein-coupled receptors. FEBS J. 272 (2005) 2914-2925
28. Milligan G. G protein-coupled receptor dimerisation: Molecular basis and relevance to function. Biochim. Biophys. Acta 1768 (2007) 825-835
29. Milligan G., and Smith N.J. Allosteric modulation of heterodimeric G-protein-coupled receptors. Trends Pharmacol. Sci. 28 (2007) 615-620
30. Morrison L.E. Time-resolved detection of energy transfer: Theory and application to immunoassays. Anal. Biochem. 174 (1988) 101-120
31. Parenty G., Appelbe S., and Milligan G. CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2-DOP receptor heterodimer. Biochem. J. 412 (2008) 245-256
32. Percherancier Y., Berchiche Y.A., Slight I., Volkmer-Engert R., Tamamura H., Fujii N., Bouvier M., and Heveker N. Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers. J. Biol. Chem. 280 (2005) 9895-9903
33. Pfleger K.D., and Eidne K.A. New technologies: Bioluminescence resonance energy transfer (BRET) for the detection of real time interactions involving G-protein coupled receptors. Pituitary 6 (2003) 141-151
34. Ramsay D., Kellett E., McVey M., Rees S., and Milligan G. Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): Hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences. Biochem. J. 365 (2002) 429-440
35. Ramsay D., Carr I.C., Pediani J., Lopez-Gimenez J.F., Thurlow R., Fidock M., and Milligan G. High-affinity interactions between human alpha1A-adrenoceptor C-terminal splice variants produce homo- and heterodimers but do not generate the alpha1L-adrenoceptor. Mol. Pharmacol. 66 (2004) 228-239
36. Rodriguez-Frade J.M., Vila-Coro A.J., de Ana A.M., Albar J.P., Martinez A., and Mellado M. The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. Proc. Natl. Acad. Sci. USA 96 (1999) 3628-3633
37. Samson M., Libert F., Doranz B.J., Rucker J., Liesnard C., Farber C.M., Saragosti S., Lapoumeroulie C., Cognaux J., Forceille C., Muyldermans G., Verhofstede C., et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382 (1996) 722-725
38. Shaner N.C., Steinbach P.A., and Tsien R.Y. A guide to choosing fluorescent proteins. Nat. Methods 2 (2005) 905-909
39. Shyu Y.J., Liu H., Deng X., and Hu C.D. Identification of new fluorescent protein fragments for bimolecular fluorescence complementation analysis under physiological conditions. Biotechniques 40 (2006) 61-66
40. Smith M.W., Dean M., Carrington M., Winkler C., Huttley G.A., Lomb D.A., Goedert J.J., O'Brien T.R., Jacobson L.P., Kaslow R., Buchbinder S., Vittinghoff E., et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 277 (1997) 959-965
41. Sohy D., Parmentier M., and Springael J.Y. Allosteric transinhibition by specific antagonists in CCR2/CXCR4 heterodimers. J. Biol. Chem. 282 (2007) 30062-30069
42. Springael J.Y., Urizar E., Costagliola S., Vassart G., and Parmentier M. Allosteric properties of G protein-coupled receptor oligomers. Pharmacol. Ther. 115 (2007) 410-418
43. Suzuki S., Chuang L.F., Yau P., Doi R.H., and Chuang R.Y. Interactions of opioid and chemokine receptors: Oligomerization of mu, kappa, and delta with CCR5 on immune cells. Exp. Cell Res. 280 (2002) 192-200
44. Toth P.T., Ren D., and Miller R.J. Regulation of CXCR4 receptor dimerization by the chemokine SDF-1alpha and the HIV-1 coat protein gp120: A fluorescence resonance energy transfer (FRET) study. J. Pharmacol. Exp. Ther. 310 (2004) 8-17
45. Trettel F., Di Bartolomeo S., Lauro C., Catalano M., Ciotti M.T., and Limatola C. Ligand-independent CXCR2 dimerization. J. Biol. Chem. 278 (2003) 40980-40988
46. Tsien R.Y. The green fluorescent protein. Annu. Rev. Biochem. 67 (1998) 509-544
47. Vidi P.A., Chemel B.R., Hu C.D., and Watts V.J. Ligand-dependent oligomerization of dopamine D(2) and adenosine A(2A) receptors in living neuronal cells. Mol. Pharmacol. 74 (2008) 544-551
48. Vila-Coro A.J., Rodriguez-Frade J.M., Martin D.A., Moreno-Ortiz M.C., Martinez A., and Mellado M. The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J. 13 (1999) 1699-1710
49. Wang J., and Norcross M. Dimerization of chemokine receptors in living cells: Key to receptor function and novel targets for therapy. Drug Discov. Today 13 (2008) 625-632
50. Wilson S., Wilkinson G., and Milligan G. The CXCR1 and CXCR2 receptors form constitutive homo- and heterodimers selectively and with equal apparent affinities. J. Biol. Chem. 280 (2005) 28663-28674
51. Wu P., and Brand L. Resonance energy transfer: methods and applications. Anal. Biochem. 218 (1994) 1-13
52. Xu Y., Piston D.W., and Johnson C.H. A bioluminescence resonance energy transfer (BRET) system: Application to interacting circadian clock proteins. Proc. Natl. Acad. Sci. USA 96 (1999) 151-156
53. Xu Y., Kanauchi A., von Arnim A.G., Piston D.W., and Johnson C.H. Bioluminescence resonance energy transfer: Monitoring protein-protein interactions in living cells. Methods Enzymol. 360 (2003) 289-301